Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. Amazon Location Service.

Clinical trial site

Cleveland Clinic

Cleveland Clinic in Cleveland, Ohio, United States is listed as a site for 1,996 registered clinical trials, 614 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 1,996
Ongoing 614

This page covers the site record Cleveland Clinic in Cleveland, Ohio, United States: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled. The organization of the same name, Cleveland Clinic, also sponsors trials.

Get the Cleveland Clinic report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 1,996 trials counted.

  • Phase 1 117 trials
  • Phase 1/2 107 trials
  • Phase 2 352 trials
  • Phase 2/3 35 trials
  • Phase 3 356 trials
  • Phase 4 97 trials
  • Not applicable 536 trials
  • Observational 373 trials
  • Expanded access 22 trials
  • Unknown 1 trial

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 621 trials
  • Completed 986 trials
  • Terminated 326 trials
  • Other 63 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational
  • Other (Unknown)

Top of scale: 135

1994: 1 trials (Phase 3 1) 1995: 1 trials (Observational 1) 1998: 2 trials (Not applicable 2) 1999: 2 trials (Phase 4 1, Phase 1 1) 2000: 2 trials (Observational 1, Phase 1/2 1) 2001: 2 trials (Observational 1, Not applicable 1) 2002: 8 trials (Observational 1, Phase 3 5, Phase 2 1, Phase 1/2 1) 2003: 9 trials (Observational 5, Not applicable 1, Phase 3 2, Phase 2 1) 2004: 8 trials (Observational 2, Not applicable 2, Phase 3 3, Phase 2 1) 2005: 21 trials (Observational 4, Not applicable 6, Phase 3 6, Phase 2 3, Phase 1 2) 2006: 31 trials (Observational 6, Not applicable 8, Phase 4 3, Phase 3 4, Phase 2/3 2, Phase 2 5, Phase 1/2 1, Phase 1 2) 2007: 59 trials (Observational 15, Not applicable 12, Phase 4 3, Phase 3 9, Phase 2/3 3, Phase 2 16, Phase 1 1) 2008: 53 trials (Observational 7, Not applicable 13, Phase 4 6, Phase 3 11, Phase 2/3 2, Phase 2 9, Phase 1/2 3, Phase 1 2) 2009: 45 trials (Observational 7, Not applicable 12, Phase 4 1, Phase 3 13, Phase 2 11, Phase 1 1) 2010: 69 trials (Observational 19, Not applicable 18, Phase 4 2, Phase 3 16, Phase 2/3 1, Phase 2 12, Phase 1 1) 2011: 61 trials (Observational 18, Not applicable 15, Phase 4 3, Phase 3 4, Phase 2/3 1, Phase 2 13, Phase 1/2 2, Phase 1 5) 2012: 77 trials (Observational 15, Not applicable 26, Phase 4 4, Phase 3 11, Phase 2 13, Phase 1/2 4, Phase 1 4) 2013: 84 trials (Observational 16, Not applicable 25, Phase 4 3, Phase 3 10, Phase 2/3 2, Phase 2 22, Phase 1/2 5, Phase 1 1) 2014: 85 trials (Observational 16, Not applicable 24, Phase 4 3, Phase 3 10, Phase 2/3 3, Phase 2 19, Phase 1/2 6, Phase 1 4) 2015: 102 trials (Observational 27, Not applicable 18, Phase 4 8, Phase 3 22, Phase 2/3 1, Phase 2 14, Phase 1/2 3, Phase 1 9) 2016: 101 trials (Observational 18, Not applicable 39, Phase 4 8, Phase 3 17, Phase 2/3 1, Phase 2 10, Phase 1/2 3, Phase 1 5) 2017: 118 trials (Observational 20, Not applicable 33, Phase 4 9, Phase 3 23, Phase 2/3 3, Phase 2 22, Phase 1/2 6, Phase 1 2) 2018: 130 trials (Observational 21, Not applicable 41, Phase 4 7, Phase 3 26, Phase 2 23, Phase 1/2 5, Phase 1 7) 2019: 118 trials (Other 1, Observational 23, Not applicable 26, Phase 4 6, Phase 3 26, Phase 2/3 1, Phase 2 25, Phase 1/2 6, Phase 1 4) 2020: 135 trials (Observational 26, Not applicable 28, Phase 4 3, Phase 3 26, Phase 2/3 1, Phase 2 26, Phase 1/2 15, Phase 1 10) 2021: 117 trials (Observational 19, Not applicable 43, Phase 4 4, Phase 3 15, Phase 2/3 3, Phase 2 16, Phase 1/2 6, Phase 1 11) 2022: 109 trials (Observational 18, Not applicable 31, Phase 4 2, Phase 3 16, Phase 2/3 1, Phase 2 16, Phase 1/2 11, Phase 1 14) 2023: 128 trials (Observational 23, Not applicable 35, Phase 4 7, Phase 3 18, Phase 2/3 4, Phase 2 21, Phase 1/2 11, Phase 1 9) 2024: 100 trials (Observational 13, Not applicable 19, Phase 4 6, Phase 3 22, Phase 2/3 1, Phase 2 19, Phase 1/2 9, Phase 1 11) 2025: 113 trials (Observational 15, Not applicable 29, Phase 4 7, Phase 3 25, Phase 2/3 4, Phase 2 21, Phase 1/2 7, Phase 1 5)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 73
2025 113
2024 100
2023 128
2022 109
2021 117
2020 135
2019 118
2018 130
2017 118

Showing 10 of 31 years.

Start your 14-day trial Email me all 31 years as a PDF

2026 is partial: trials registered with a 2026 start date so far, not a full year. 7 trials are registered to start in 2027 or later, and not listed here

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Showing 5 of 1,996 trials.

Start your 14-day trial Email me the first 50 trials as a PDF

Source: ClinicalTrials.gov

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Showing 5 of 621 lead sponsors.

Start your 14-day trial Email me the first 50 lead sponsors as a PDF

Conditions studied

The specific conditions of the trials that list this site, most trials first.

Showing 5 of 767 conditions.

Start your 14-day trial Email me the first 50 conditions as a PDF